Navigation Links
Edwards Lifesciences to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
Date:2/1/2008

IRVINE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Edwards Lifesciences Corporation (NYSE: EW), a world leader in products and technologies to treat advanced cardiovascular disease, is scheduled to participate in the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference at the Grand Hyatt Hotel in New York on Thursday, February 7, 2008.

Thomas M. Abate, Edwards Lifesciences' corporate vice president, chief financial officer & treasurer, is scheduled to speak to conference attendees at 11:00 a.m. ET. A live webcast of the presentation will be available to all interested parties on the Edwards Lifesciences investor relations website at http://www.edwards.com/InvestorRelations/EventCalendar.htm. An archived version of the webcast will be available later that day on the Edwards investor relations website in the News and Events section.

About Edwards Lifesciences

Edwards Lifesciences, a leader in advanced cardiovascular disease treatments, is the number-one heart valve company in the world and the global leader in acute hemodynamic monitoring. Headquartered in Irvine, Calif., Edwards focuses on specific cardiovascular disease states including heart valve disease, vascular disease and critical care technologies. The company's global brands, which are sold in approximately 100 countries, include Carpentier-Edwards, Cosgrove-Edwards, FloTrac, Fogarty, PERIMOUNT Magna and Swan-Ganz. Additional company information can be found at http://www.edwards.com.

Edwards and FloTrac are trademarks of Edwards Lifesciences Corporation. Edwards Lifesciences, Carpentier-Edwards,
'/>"/>

SOURCE Edwards Lifesciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Favrille to Present at AG Edwards Emerging Growth Conference and Wall Street Analyst Forum
2. Bionovo to Present at A.G. Edwards 2nd Annual Emerging Growth Conference 2007
3. Edwards Lifesciences Grants UC Irvine $5 Million to Establish the Edwards Lifesciences Center for Advanced Cardiovascular Technology
4. Medarex to Present at the A.G. Edwards 2nd Annual Emerging Growth Conference
5. Marshall Edwards, Inc. to Present at BIO Investor Forum 2007
6. Edwards Lifesciences Forecasts Strong Growth in 2008
7. Edwards Lifesciences Completes Acquisition of CardioVations Product Line
8. Edwards Lifesciences Receives FDA Approval to Add Transapical Delivery System to U.S. Clinical Trial of Transcatheter Heart Valve
9. Edwards Lifesciences to Host Earnings Conference Call on February 5, 2008
10. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
11. Avicena Group to Present at Noble Financial Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2008)...all/ -- Bioheart, Inc. (Nasdaq:,BHRT) a biotechnol...autologous (patient-derived) cell therapies and de... damage, today announced it has been added to the,...t Group reconstituted its,comprehensive set of U.S...cording to the Russell Investment Group, the Russe...
(Date:7/2/2008)...rma, a leading provider of,knowledge management so...e,industry, announced today that the Aureus Pharma...ber 23rd and 24th., This symposium follows last y...attended by many of Aureus, pharmaceutical and bio... The symposium included presentations,from industr...
(Date:7/2/2008).../ -- Research conducted at The,Walter and Eliza Ha...to a,major licensing agreement signed between Aust... and Germany-based pharmaceutical company, Merck,S...ment, Merck Serono will seek,to develop new treatm...une,conditions. These prospective treatments will ...
(Date:7/1/2008)...stCall/ -- Schering-Plough,Corporation (NYSE: SGP...reviously announced transaction with Virbac, S.A. ...nchises. These divestments were requested by the,E...arance of the,acquisition of Organon BioSciences N... endocrine, mastitis and,sulphonamide franchises o...
Breaking Biology Technology:Bioheart, Inc., Added to Russell Microcap Index 2Aureus Pharma Announces Date of 2008 Annual User Symposium 2MS Drug Development Agreement Based on WEHI's Medicinal Chemistry 2Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products 2
...nal , a Wisconsin-based pharmaceutical firm, repor...eing a 103 percent increase in sales and raising t... , ,BoneCare,s fourth-quarter net income has been ...and twice the last quarter,s first-ever profit of ...rter from $7.3 million to $14.7 million, bringing ...
...o a new product, behave just like parents jumping ...ical hoopla of the incubation wing is often replac...omes a subdued Dilbertish style revolution. Object... sharp yet harmless, foamy projectiles. Everyone s...tioned. Everyone wants a successful launch. There ...
... Wisconsin, which means the golfing world will bea...orsteps, the 7,514-yard Whistling Straits course i...nd, Cliff Hanger and Voyageur, it,s an inspiring p...sin boasts another course, equally impressive, tha... visitors who might be tempted to return another d...
...for search term "Disney" MADISON NameProtect Inc....gence company, has released the results of an anal...extual advertisements within standard search engin...tings at search engines Google and Yahoo! for ...party advertising on these trademarked terms, with...
Other Biology Technology:BoneCare doubles options and profits as fiscal year closes 2Naming that thing... again? 2Naming that thing... again? 3Naming that thing... again? 4Above par: Playing 18 holes on Wisconsin's high-tech course 2Above par: Playing 18 holes on Wisconsin's high-tech course 3NameProtect study shows 92% of top brands losing out on search engines 2NameProtect study shows 92% of top brands losing out on search engines 3
(Date:7/2/2008)...NUT CREEK, CAIn the continuing effort to tap the v...nd plant domains for bioenergy and environmental a...GI) has announced its latest portfolio of DNA sequ...ng year. The 44 projects, culled from nearly 150 p... Program (CSP), represent over 60 billion nucleoti...
(Date:7/2/2008)...nd Forks, North Dakota, July 2, 2008 Volunteers r...ion International (JDRF), the American Diabetes As...rd (NIHB) will present Senator Byron Dorgan with t...dership on extending the Special Diabetes Program ...:30 a.m. in the Buchli Room at the Hilton Garden I...
(Date:7/2/2008)...h the goal of developing an accurate, powerful and...ngth, scientists of the ETH Zurich Departments of ...ience teamed up with supercomputing experts at IBM...ethod developed by the team combines density measu...the inner-bone microstructure. , Using large-sc...
(Date:7/2/2008)...LD SPRING HARBOR, N.Y. (Tuesday, July 1, 2008) ...ts with the International Haplotype Map Project ha...a tool that displays common patterns of genetic va...e for unrestricted public use from the project,s w... browse the map can be difficult to master for the...
Breaking Biology News(10 mins):US Department of Energy Joint Genome Institute announces new genome sequencing projects 2US Department of Energy Joint Genome Institute announces new genome sequencing projects 3US Department of Energy Joint Genome Institute announces new genome sequencing projects 4US Department of Energy Joint Genome Institute announces new genome sequencing projects 5US Department of Energy Joint Genome Institute announces new genome sequencing projects 6US Department of Energy Joint Genome Institute announces new genome sequencing projects 7Sen. Byron Dorgan to be honored 2ETH Zurich and IBM improve diagnosis of osteoporosis 2HapMap browsing and DDDP methods for genetic analysis featured in CSH Protocols 2Actress Producer Salma Hayek Launches The Pampers 28R 29 One Pack 3D One Vaccine Program to Benefit UNICEF 16176 1Actress Producer Salma Hayek Launches The Pampers 28R 29 One Pack 3D One Vaccine Program to Benefit UNICEF 16176 2Actress Producer Salma Hayek Launches The Pampers 28R 29 One Pack 3D One Vaccine Program to Benefit UNICEF 16176 3Actress Producer Salma Hayek Launches The Pampers 28R 29 One Pack 3D One Vaccine Program to Benefit UNICEF 16176 4Actress Producer Salma Hayek Launches The Pampers 28R 29 One Pack 3D One Vaccine Program to Benefit UNICEF 16176 5Greetings From Menopauseland 16173 1Greetings From Menopauseland 16173 2Greetings From Menopauseland 16173 3Journey Lite of Thousand Oaks Announces Special Spring Price Discount In Response to Effects of Softening Economy on Patients Pocketbooks 16170 1Journey Lite of Thousand Oaks Announces Special Spring Price Discount In Response to Effects of Softening Economy on Patients Pocketbooks 16170 2Martek Announces Final Judgment and Order of Dismissal in Class Action 4443 1Martek Announces Final Judgment and Order of Dismissal in Class Action 4443 2
...l surface proteins that generate the strongest imm...y of Chicago have created a vaccine that significa...ase-causing, drug-resistant strains of Staphylococ...ired infections and a rapidly spreading source of ...cted mice against potentially lethal infections wi...
... normal food intake and metabolism, exerts a stron...gion as well as in the hypothalamus, according to ...ding that metabolic hormones directly regulate the... profound implications for how researchers view th...said the senior author, Ralph DiLeone, assistant p...
...that used thermal imaging technology for the first...ned the conventional wisdom that women become arou...Comparing sexual arousal between men and women, we...time it takes healthy young men and women to reach...fessor and founder and director of the Sex and Cou...
... of Wisconsin-Madison School of Medicine and Publi...ted mechanism that governs the formation of blood ... halt tumor growth in cancer patients, says Emery ...sor of pharmacology and member of the UW-Madison P...he research, published in the Journal of Cell Biol...
Other Biology News:MRSA vaccine shows promise in mouse study 2MRSA vaccine shows promise in mouse study 3Thermal imaging shatters arousal gender gap myth 2New angiogenesis finding may help fight cancer growth 2New angiogenesis finding may help fight cancer growth 3New angiogenesis finding may help fight cancer growth 4
Goat polyclonal to PPP2R5D Immunogen: Peptide with sequence KRAEEFLTASQEAL, from C Terminus of the protein sequence according to NP_006236
TNR-R2
Rabbit polyclonal to IL23 P19 ( Abpromise for all tested applications). Antigen: Synthetic 16 amino acid peptide from near the amino terminus of human IL23 P19 Entrez Gene ID: 51561 Swiss
Acetyl-Histone H3 Immunoprecipitation (ChIP) Assay Kit from Upstate
Biology Products: